This is a study of biomarkers obtained from prospectively collected subject samples and their correlation with cardiovascular and metabolic diseases. The purpose of this initiative is to develop an enduring tool to allow for collaborative research between clinicians at Cleveland Clinic Main Campus and basic scientists at the Lerner Research Institute. This collaboration will allow resources to be available to clinical and basic researchers alike. This tool will enable research of vascular disease in the Vascular Lab and will leverage this valuable asset to the fullest extent to allow for interdepartmental collaboration.
18 years or older
Subjects capable of providing informed consent document
Subjects with diagnosed with or at risk for cardiovascular and metabolic diseases
Known life expectancy of ≤ 6 months at the time of enrollment
Known current pregnancy
Severe Anemia (last documented hemoglobin < 7.0 g/dL)
Patients who are with or at risk for cardiovascular or metabolic disease.
Case-only
Prospective
Not listed
To collect blood, urine, and/or stool samples for biorepository
To explore pathways of thrombosis, inflammation, gut microbiome, alterations in cell signaling, lipid metabolism and other metabolic pathways in vascular diseases
Click on the lead sponsor to view all of their trials.
